his hers semaglutide Ticker: Hims & drops plans for knockoff weight loss pill; Washington Post editor steps down Hims Inc. - Novo Nordisk's

Volpe S, et al

Horizant bypasses this saturation limitation, delivering approximately 74% bioavailability compared to only 27-60% for immediate-release gabapentin

2

There is still limited literature on how glucagon-like peptide (GLP-1) injections affect a patient's chance of developing cancer, but there are enough findings to show that patients should be wary

NICE approved semaglutide (Wegovy) for weight management in specialist NHS weight management services in 2023 (TA875), but availability is limited to patients with: BMI 35 kg/m with at least one weight-related comorbidity, or BMI 30 kg/m with exceptional circumstances Lower BMI thresholds apply for people from some minority ethnic groups (typically 27.5 kg/m) Participation in a specialist weight management programme Treatment limited to a maximum of 2 years Access varies by region due to local integrated care board (ICB) implementation decisions and limited NHS specialist service capacity